Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 724 of 1,261

  1. US 9181277

    Aminoquinazoline derivatives and their salts and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  2. US 9181306

    Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  3. US 9181273

    Morpholine-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  4. US 9181253

    Adenosine receptor agonists, partial agonists, and antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  5. US 9181231

    Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia

    Agios Pharmaceuticals, Inc. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  6. US 9181249

    Substituted pyrido[3,4-b]pyrazines as GPR6 modulators

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  7. US 9181220

    N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  8. US 9181186

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  9. US 9180196

    Photodegradable groups for tunable polymeric materials

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  10. US 9180198

    Slow-release cilostazol tablet having an improved elution rate and minimal side effects

    KOREA UNITED PHARM. INC. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  11. US 9180197

    Sustained delivery formulations of risperidone compounds

    Indivior UK Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  12. US 9180395

    Porous thin films

    The Regents of the University of California · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  13. US 9180113

    Tocotrienol compositions

    First Tech International Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  14. US 9180179

    Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  15. US 9180097

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  16. US 9180212

    β-amyloid plaque imaging agents

    The Regents of the University of California · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  17. US 9180091

    Soluble estradiol capsule for vaginal insertion

    Compass Therapeutics LLC · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  18. US 9180147

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  19. US 9180144

    Decellularisation of tissue matrices for bladder implantation

    Tissue Regenix Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  20. US 9180143

    Decellularisation of tissue matrices for bladder implantation

    Tissue Regenix Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  21. US 9181330

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  22. US 9180152

    Method for treating psoriasis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  23. US 9181255

    Fused heteroaromatic pyrrolidinones as SYK inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  24. US 9180115

    Cyclohexylamines

    Asana BioSciences, LLC · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.